Regarding the latter, a recent paper showed the persistence of CD26+ LSCs in peripheral blood of CML patients in molecular response, receiving TKI treatment or after TKI discontinuation (11). The gene discussed is DPP4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.